HealthPlix Technologies, India’s AI-powered EMR software company, announced the release of its new feature – ‘Drug to Drug Interaction’ (DDI). DDI is an intuitive feature that sits on the HealthPlix EMR to help doctors recall molecule-to-molecule interactions at the time of care. The suggestive feature is designed for doctors in India and targeted to decrease their time taken to write a prescription.
The feature is live on the HealthPlix platform and optimized for prompting these interactions while the doctor prescribes the medicines to their patients. “Our vision is to build assistive technologies for doctors so that they can help improve patient health outcomes. DDI launch is an important step towards that vision. HealthPlix’s interactive cloud based EMR platform allows us to nudge the doctor with key medical information at the point of care,” says Chaitanya Raju, Chief of AI, HealthPlix Technologies.
Commenting on the experience, Dr. Peyush Khera, Consultant Cardiologist using the HealthPlix platform said, “This new feature is quite useful as a ready reckoner for reminding us about potential interactions between molecules prescribed. In addition to prescribing medicine based on diagnosis, DDI provides suggestions for drugs that may be relevant to the treatment course.”